Video Experimental Relacionado

Updated: Jun 28, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.1K

Avances en las pruebas ecotoxicológicas acuáticas de fármacos anticancerígenos a través de mesocosmos

Andrea Carboni1,2, Matteo Calvaresi1,2

  • 1Dipartimento di Chimica "Giacomo Ciamician", Alma Mater Studiorum-Università di Bologna, Via Piero Gobetti, 85, 40129 Bologna, Italy.

Molecules (Basel, Switzerland)
|December 31, 2025
PubMed
Resumen

Los fármacos anticancerígenos (ACD) contaminan los entornos acuáticos, lo que supone un riesgo para los organismos no destinatarios. Los estudios de mesocosmos ofrecen un enfoque realista para evaluar los ACD

Palabras clave:
ecosistemas acuáticosquimioterapéuticosecotoxicidadcontaminantes emergentesimpacto ambiental

Más Videos Relacionados

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.7K
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.7K

Videos de Conceptos Relacionados

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...